Historian Bruce Venter talked about Ethan Allen's background and his role during the French and Indian War. This event was part of the 2025 American Revolution conference at Fort Plain Museum & ...

First Pacific Advisors shares Source Capital’s Q2 2025 outlook, highlighting disciplined positioning amid volatility.

SU offers high returns, top-tier execution & value stability via integration. Still, oil price risk & high maintenance capital may pressure performance.

Cotality™, a leader in property information, analytics, and data-enabled solutions, released its Home Price Index™ for July ...

Regenxbio's RGX-121 gene therapy for Hunter syndrome is the main catalyst, with FDA approval targeted for February 2026.